WHO issues an emergency use validation for the vaccine against coronavirus to Pfizer and BioNTech

Geneva (Switzerland): The World Health Organization said on Thursday it had issued an emergency use validation for the vaccine against the coronavirus developed by the Pfizer and BioNTech companies, the first one since the start of the pandemic.

“The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago,” the WHO said in a statement.

India closer to Covid-19 vaccine, Drug Controller hints for approval
The WHO decision has enabled UNICEF and the Pan-American Health Organization to procure the vaccine for distribution to the countries in need.

“WHO and our partners are working night and day to evaluate other vaccines that have reached safety and efficacy standards. We encourage even more developers to come forward for review and assessment. It’s vitally important that we secure the critical supply needed to serve all countries around the world and stem the pandemic,” WHO Assistant-Director General for Access to Medicines and Health Products Mariangela Simao said.

This 'Vaccine' can be highly effective against new COVID-19 strain, hints Russian vaccine developer

The WHO declared the COVID-19 outbreak a pandemic on March 11. To date, more than 83.1 million people have been infected with the coronavirus worldwide, with over 1.81 million fatalities, according to Johns Hopkins University.

The post WHO issues an emergency use validation for the vaccine against coronavirus to Pfizer and BioNTech appeared first on NewsroomPost.



from NewsroomPost https://ift.tt/3hx3g3j
https://ift.tt/3hAdVdm

Comments